Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00003 | 35259337 | Chem Phys Lipids | New insights into NAFLD based on preclinical MRI studies. | 2022 | Details |
| A00005 | 35258483 | Endocr Connect | Menopause-associated risk of cardiovascular disease. | 2022 | Details |
| A00009 | 35256195 | Thromb Res | Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease. | 2022 | Details |
| A00012 | 35255597 | Endocrinol Metab (Seoul) | The Influence of Obesity and Metabolic Health on Vascular Health. | 2022 | Details |
| A00024 | 35251356 | EFSA J | Tolerable upper intake level for dietary sugars. | 2022 | Details |
| A00025 | 35251100 | Front Plant Sci | Raffinose Family Oligosaccharides: Friend or Foe for Human and Plant Health? | 2022 | Details |
| A00031 | 35250588 | Front Pharmacol | Platelets in Non-alcoholic Fatty Liver Disease. | 2022 | Details |
| A00032 | 35250014 | Ultrasound Q | Clinical Feasibility of Shear Wave Dispersion Slope for Noninvasive Diagnosis of Nonalcoholic Steatohepatitis in Patients With Morbid Obesity: Preliminary Results Using US Shear Wave Elastography. | 2022 | Details |
| A00037 | 35248654 | Diabetes Res Clin Pract | Metabolic determinants of NAFLD in adults with type 1 diabetes. | 2022 | Details |
| A00038 | 35248539 | Gastroenterology | NAFLD and the Gut-Liver Axis: Exploring an Undernutrition Perspective. | 2022 | Details |
| A00039 | 35247883 | Cancer Epidemiol Biomarkers Prev | Cancer epidemiology in Hispanic populations: what have we learned and where do we need to make progress? | 2022 | Details |
| A00041 | 35247611 | Mol Metab | Serum Amyloid A1 Exacerbates Hepatic Steatosis via TLR4 Mediated NF-κB Signaling Pathway. | 2022 | Details |
| A00045 | 35245436 | Mol Cell | Amelioration of hepatic steatosis by dietary essential amino acid-induced ubiquitination. | 2022 | Details |
| A00058 | 35238782 | Turk J Gastroenterol | Evaluation of Magnetic Resonance Elastography and Transient Elastography for Liver Fibrosis and Steatosis Assessments in the Liver Transplant Setting. | 2022 | Details |
| A00059 | 35238641 | Proc Natl Acad Sci U S A | Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease. | 2022 | Details |
| A00069 | 35232986 | Sci Rep | Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation. | 2022 | Details |
| A00074 | 35230042 | Swiss Med Wkly | Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis. | 2022 | Details |
| A00075 | 35229847 | Food Funct | N-Acetylcysteine alleviates high fat diet-induced hepatic steatosis and liver injury via regulating the intestinal microecology in mice. | 2022 | Details |
| A00076 | 35229334 | Aliment Pharmacol Ther | Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study. | 2022 | Details |
| A00077 | 35229329 | Hepatology | Risk Factors for Hepatocellular Cancer in Contemporary Cohorts of Patients with Cirrhosis. | 2022 | Details |
| A00079 | 35229049 | Health Sci Rep | Associations between aflatoxin B1-albumin adduct levels with metabolic conditions in Guatemala: A cross-sectional study. | 2022 | Details |
| A00081 | 35227956 | Clin Res Hepatol Gastroenterol | Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with Covid-19. | 2022 | Details |
| A00094 | 35222044 | Front Pharmacol | Antibiotic Disruption of the Gut Microbiota Enhances the Murine Hepatic Dysfunction Associated With a High-Salt Diet. | 2022 | Details |
| A00097 | 35220673 | Liver Int | Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes. | 2022 | Details |
| A00103 | 35218234 | Hepatology | Dual roles of B lymphocytes in murine models of diet-induced non-alcoholic fatty liver disease. | 2022 | Details |
| A00105 | 35218194 | J Nutr | Clinical Intervention to Reduce Dietary Sugar does not Impact Liver Fat in Latino Youth, Regardless of PNPLA3 Genotype: A Randomized Controlled Trial. | 2022 | Details |
| A00106 | 35217953 | Environ Sci Pollut Res Int | Environmental exposure to low-dose perfluorohexanesulfonate promotes obesity and non-alcoholic fatty liver disease in mice fed a high-fat diet. | 2022 | Details |
| A00107 | 35217817 | Acta Pharmacol Sin | Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease. | 2022 | Details |
| A00112 | 35216556 | BMC Endocr Disord | Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease. | 2022 | Details |
| A00113 | 35216439 | Int J Mol Sci | Heat-Inactivated Akkermansia muciniphila Improves Gut Permeability but Does Not Prevent Development of Non-Alcoholic Steatohepatitis in Diet-Induced Obese Ldlr-/-.Leiden Mice. | 2022 | Details |
| A00114 | 35216326 | Int J Mol Sci | New Insights in the Control of Fat Homeostasis: The Role of Neurotensin. | 2022 | Details |
| A00115 | 35216174 | Int J Mol Sci | Whole Body Ip6k1 Deletion Protects Mice from Age-Induced Weight Gain, Insulin Resistance and Metabolic Dysfunction. | 2022 | Details |
| A00126 | 35212997 | Methods Mol Biol | Metabolic Phenotyping in Mice with NASH Using Indirect Calorimetry. | 2022 | Details |
| A00137 | 35212983 | Methods Mol Biol | Hydrodynamic Injection for Developing NASH Model. | 2022 | Details |
| A00138 | 35212982 | Methods Mol Biol | Generation of a Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00147 | 35208513 | Medicina (Kaunas) | Evaluation of Dose-Dependent Obesity and Diabetes-Related Complications of Water Chestnut (Fruit of Trapa japonica) Extracts in Type II Obese Diabetic Mice Induced by 45% Kcal High-Fat Diet. | 2022 | Details |
| A00149 | 35208241 | Metabolites | Assessment of Exposure to Di-(2-ethylhexyl) Phthalate (DEHP) Metabolites and Bisphenol A (BPA) and Its Importance for the Prevention of Cardiometabolic Diseases. | 2022 | Details |
| A00150 | 35208229 | Metabolites | The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents. | 2022 | Details |
| A00157 | 35204710 | Biomolecules | Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases. | 2022 | Details |
| A00160 | 35204232 | Antioxidants (Basel) | Dietary Selenium Alleviated Mouse Liver Oxidative Stress and NAFLD Induced by Obesity by Regulating the KEAP1/NRF2 Pathway. | 2022 | Details |
| A00162 | 35203687 | Biomedicines | A Novel 2-Hit Zebrafish Model to Study Early Pathogenesis of Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00163 | 35203662 | Biomedicines | The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical Features. | 2022 | Details |
| A00166 | 35203502 | Biomedicines | Impact of Maternal Obesity on Liver Disease in the Offspring: A Comprehensive Transcriptomic Analysis and Confirmation of Results in a Murine Model. | 2022 | Details |
| A00168 | 35203457 | Biomedicines | Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences. | 2022 | Details |
| A00172 | 35201574 | Hepatol Int | Gender differences in the association of body composition and biopsy-proved nonalcoholic steatohepatitis. | 2022 | Details |
| A00174 | 35198905 | iScience | Deletion of RNF186 expression suppresses diet-induced hepatic steatosis by regulating insulin activity. | 2022 | Details |
| A00179 | 35196511 | Am J Med Sci | Deciphering the Role of Aquaporins in Metabolic Diseases: A Mini Review. | 2022 | Details |
| A00181 | 35195774 | Arch Microbiol | A review on the effect of gut microbiota on metabolic diseases. | 2022 | Details |
| A00182 | 35195697 | JAMA Netw Open | Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00185 | 35194014 | Nutr Diabetes | Growth differentiation factor 15 (GDF15) is associated with non-alcoholic fatty liver disease (NAFLD) in youth with overweight or obesity. | 2022 | Details |
| A00196 | 35190444 | BMJ Open | Association between intrahepatic triglyceride content in subjects with metabolically healthy abdominal obesity and risks of pre-diabetes plus diabetes: an observational study. | 2022 | Details |
| A00208 | 35185803 | Front Endocrinol (Lausanne) | Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00212 | 35183303 | Lancet Diabetes Endocrinol | A global view of the interplay between non-alcoholic fatty liver disease and diabetes. | 2022 | Details |
| A00220 | 35178663 | Hepatol Int | Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank. | 2022 | Details |
| A00227 | 35176047 | PLoS One | Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in Bangkok, Thailand. | 2022 | Details |
| A00235 | 35172845 | Nutr Metab (Lond) | Effects of exercise on high-fat diet-induced non-alcoholic fatty liver disease and lipid metabolism in ApoE knockout mice. | 2022 | Details |
| A00236 | 35172328 | J Clin Endocrinol Metab | Growth hormone and insulin-like growth factor I regulation of nonalcoholic fatty liver disease. | 2022 | Details |
| A00240 | 35171164 | Food Funct | Tangeretin improves hepatic steatosis and oxidative stress through the Nrf2 pathway in high fat diet-induced nonalcoholic fatty liver disease mice. | 2022 | Details |
| A00246 | 35167495 | JCI Insight | Ethnic and gender differences in hepatic lipid content and related cardiometabolic parameters in lean individuals. | 2022 | Details |
| A00247 | 35167194 | J Diabetes Investig | Fatty liver with metabolic disorder, such as metabolic dysfunction-associated fatty liver disease, indicates high risk for developing diabetes mellitus. | 2022 | Details |
| A00255 | 35163991 | Molecules | Sitagliptin Is More Effective Than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00256 | 35163881 | Molecules | The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models. | 2022 | Details |
| A00257 | 35163821 | Int J Mol Sci | Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome. | 2022 | Details |
| A00258 | 35163521 | Int J Mol Sci | The Regulatory Role of the Central and Peripheral Serotonin Network on Feeding Signals in Metabolic Diseases. | 2022 | Details |
| A00260 | 35162992 | Int J Mol Sci | Emerging Insights on the Diverse Roles of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Chronic Liver Diseases: Cholesterol Metabolism and Beyond. | 2022 | Details |
| A00262 | 35162956 | Int J Mol Sci | Emergent Roles of Circular RNAs in Metabolism and Metabolic Disorders. | 2022 | Details |
| A00266 | 35160329 | J Clin Med | Influence of Body Mass Index, Cancer Type and Treatment on Long-Term Metabolic and Liver Outcomes in Childhood Cancer Survivors. | 2022 | Details |
| A00267 | 35160204 | J Clin Med | Liraglutide + PYY3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements. | 2022 | Details |
| A00269 | 35159371 | Cells | The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period. | 2022 | Details |
| A00278 | 35154523 | Arch Med Sci | Fibroblast growth factor 21 levels and liver inflammatory biomarkers in obese subjects after weight loss. | 2021 | Details |
| A00279 | 35154005 | Front Endocrinol (Lausanne) | Novel Subgroups and Chronic Complications of Diabetes in Middle-Aged and Elderly Chinese:A Prospective Cohort Study. | 2022 | Details |
| A00282 | 35152974 | Adv Clin Chem | Advances in fibrosis biomarkers in nonalcoholic fatty liver disease. | 2021 | Details |
| A00287 | 35152446 | Hepatology | FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP-activated protein kinase-Caspase 6 signal axis. | 2022 | Details |
| A00288 | 35152443 | J Food Sci | Bentong ginger oleoresin mitigates liver injury and modulates gut microbiota in mouse with nonalcoholic fatty liver disease induced by high-fat diet. | 2022 | Details |
| A00291 | 35150905 | Mol Metab | ITCH E3 ubiquitin ligase downregulation compromises hepatic degradation of branched-chain amino acids. | 2022 | Details |
| A00304 | 35144052 | Redox Biol | The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities. | 2022 | Details |
| A00306 | 35143562 | PLoS One | Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population. | 2022 | Details |
| A00319 | 35138995 | Pharm Biol | Jinlida granules ameliorate the high-fat-diet induced liver injury in mice by antagonising hepatocytes pyroptosis. | 2022 | Details |
| A00320 | 35138548 | Intern Emerg Med | NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study. | 2022 | Details |
| A00322 | 35136128 | Sci Rep | Favorable association between Mediterranean diet (MeD) and DASH with NAFLD among Iranian adults of the Amol Cohort Study (AmolCS). | 2022 | Details |
| A00324 | 35134508 | J Nutr Biochem | Mechanisms of autophagic responses to altered nutritional status. | 2022 | Details |
| A00325 | 35134507 | J Nutr Biochem | Green tea extract increases adiponectin and PPAR α levels to improve hepatic steatosis. | 2022 | Details |
| A00326 | 35134438 | Life Sci | Fluorene-9-bisphenol exposure decreases locomotor activity and induces lipid-metabolism disorders by impairing fatty acid oxidation in zebrafish. | 2022 | Details |
| A00331 | 35133139 | Environ Sci Technol | 3-tert-Butyl-4-hydroxyanisole Impairs Hepatic Lipid Metabolism in Male Mice Fed with a High-Fat Diet. | 2022 | Details |
| A00333 | 35132345 | Oxid Med Cell Longev | Differentially Expressed Hepatic Genes Revealed by Transcriptomics in Pigs with Different Liver Lipid Contents. | 2022 | Details |
| A00338 | 35129307 | Liver Int | Anti-CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non-alcoholic steatohepatitis models. | 2022 | Details |
| A00339 | 35129295 | Liver Int | Differential fuel utilization in liver transplant recipients and its relationship with non-alcoholic fatty liver disease. | 2022 | Details |
| A00342 | 35127372 | Acta Pharm Sin B | The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. | 2021 | Details |
| A00344 | 35126846 | World J Hepatol | Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence. | 2022 | Details |
| A00354 | 35124268 | Clin Gastroenterol Hepatol | Mendelian Randomization Analysis Reveals No Causal Relationship Between Nonalcoholic Fatty Liver Disease and Severe COVID-19. | 2022 | Details |
| A00357 | 35122420 | Pediatr Obes | Exposure to maternal fuels during pregnancy and offspring hepatic fat in early childhood: The healthy start study. | 2022 | Details |
| A00359 | 35121786 | Sci Rep | Pericardial fat, thoracic peri-aortic adipose tissue, and systemic inflammatory marker in nonalcoholic fatty liver and abdominal obesity phenotype. | 2022 | Details |
| A00360 | 35120767 | Med Clin (Barc) | Bariatric surgery and non-alcoholic fatty liver disease. | 2022 | Details |
| A00363 | 35119232 | J Basic Clin Physiol Pharmacol | Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data. | 2022 | Details |
| A00364 | 35118444 | touchREV Endocrinol | Potential Role of Dexamphetamine in the Treatment of Non-alcoholic Fatty Liver Disease: Hopes and Pitfalls. | 2021 | Details |
| A00374 | 35112237 | Handb Exp Pharmacol | The Circadian Clock and Obesity. | 2022 | Details |
| A00375 | 35111794 | Front Nutr | Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. | 2022 | Details |
| A00378 | 35111461 | Cureus | Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A00379 | 35110952 | World J Gastroenterol | Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. | 2022 | Details |
| A00380 | 35109946 | Nutr Res Rev | NAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways. | 2021 | Details |